Dr. Stephanie B. Seminara, MD
Claim this profileMassachusetts General Hospital
Studies Congenital Hypogonadotropic Hypogonadism
Studies Hypogonadotropic Hypogonadism
11 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Stephanie B. Seminara, MD is currently running
Kisspeptin
for Low Testosterone
The goal of this study is to develop novel treatments for patients with a condition called hypogonadotropic hypogonadism (HH) through the use of exogenous kisspeptin.
Recruiting1 award Phase 215 criteria
Subcutaneous Kisspeptin
for Fertility Issues
The goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in women with hypothalamic amenorrhea (HA). The investigators are also examining whether kisspeptin can help women release eggs from their ovaries. Kisspeptin will be administered subcutaneously (SC) for two weeks in a pulsatile fashion. Ultrasound monitoring of ovarian follicular growth and frequent blood sampling (every 10 minutes for up to two hours) will be performed to assess the physiologic response to kisspeptin over time.
Recruiting1 award Phase 16 criteria
More about Stephanie B. Seminara, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Stephanie B. Seminara, MD has experience with
- GnRH
- Kisspeptin 112-121
- Kisspeptin 112-121
- Naloxone
- Kisspeptin, GnRH
- Gonadotropin Releasing Hormone (GnRH)
Breakdown of trials Stephanie B. Seminara, MD has run
Congenital Hypogonadotropic Hypogonadism
Hypogonadotropic Hypogonadism
Polycystic Ovary Syndrome
Polycystic Ovarian Syndrome
Hypogonadotropic hypogonadism
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie B. Seminara, MD specialize in?
Stephanie B. Seminara, MD focuses on Congenital Hypogonadotropic Hypogonadism and Hypogonadotropic Hypogonadism. In particular, much of their work with Congenital Hypogonadotropic Hypogonadism has involved Factor V Leiden negative patients, or patients who are undergoing treatment.
Is Stephanie B. Seminara, MD currently recruiting for clinical trials?
Yes, Stephanie B. Seminara, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Stephanie B. Seminara, MD has studied deeply?
Yes, Stephanie B. Seminara, MD has studied treatments such as GnRH, Kisspeptin 112-121, kisspeptin 112-121.
What is the best way to schedule an appointment with Stephanie B. Seminara, MD?
Apply for one of the trials that Stephanie B. Seminara, MD is conducting.
What is the office address of Stephanie B. Seminara, MD?
The office of Stephanie B. Seminara, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.